In neuroblastoma cells, P2X7 inhibition not only reduced tumor progression but was also shown to influence metabolic activity via Akt pathway and angiogenesis through reduced vascular endothelial growth factor (VEGF) secretion (Amoroso et al., 2015). Here, AKT1 is linked to neuroblastoma.